KOSUNI KOREA
Korean News in English
News

What a Hepatocellular Carcinoma Patient Should Know Before Liver Transplantation

Published September 18, 2026 · 3 views
What a Hepatocellular Carcinoma Patient Should Know Before Liver Transplantation

What a Hepatocellular Carcinoma Patient Should Know Before Liver Transplantation

When a patient diagnosed with hepatocellular carcinoma (HCC) considers liver transplantation, the first thing to verify is the possibility and success rate of living donor liver transplantation. Recent studies show that patients previously deemed ineligible for transplantation now have a 95% one-year survival rate through living donor liver transplants, even when blood types differ. This marks a significant advancement as it demonstrates that liver transplants are possible despite blood type discrepancies.

From the donor's perspective, only a small incision in the pelvic area is needed to safely donate part of the liver, resulting in minimal risk of complications for the donor. Additionally, 90% of HCC cases are associated with underlying conditions such as cirrhosis or chronic hepatitis, making early detection crucial for successful treatment.

Success Stories and Technological Advances in Living Donor Liver Transplantation

Seoul National University Hospital achieved its 3,000th liver transplant on March 5, 2026, demonstrating the stability of living donor liver transplantation technology. On March 13, 2025, South Korea's liver transplantation technology was transferred to Mongolia, providing new life to 300 patients. Meanwhile, the Liver Transplantation Center at Bucheon St. Mary's Hospital celebrated its fifth anniversary on October 10, 2023.

These success stories highlight the technological stability of liver transplants and open new treatment opportunities for HCC patients. As liver transplant facilities expand, more options become available for cancer patients.

The Importance of Early Detection in Liver Cancer

HCC is associated with underlying conditions in 90% of cases, primarily cirrhosis or chronic hepatitis. For early detection, it is recommended to undergo two types of tests twice a year—such as ultrasound and blood tests.

Early diagnosis significantly increases treatment success rates, allowing for consideration of various options including liver transplantation. Managing the underlying condition is particularly important to reduce the risk of HCC development.

Blood Type Compatibility in Liver Transplantation

Previously, blood type differences made liver transplants difficult, but recent technological advancements now allow transplants even when blood types differ. This means that a transplant can be performed regardless of blood type compatibility between donor and recipient.

The concern over blood type mismatch has largely been resolved, expanding the possibility of liver transplantation. For patients like those with HCC, this means surgery can still be considered even if there is a blood type difference.

Donor Safety Procedures and Living Donor Transplantation

In living donor liver transplants, donors donate part of their liver through a small incision in the pelvic area. This method is safer than traditional transplants and has minimal side effects for the donor.

Recovery time for donors is relatively short, allowing them to return to normal daily activities quickly. This indicates that living donor transplantation offers positive outcomes for both patients and donors.

심철종 간암 환자, 간이식 수술 전 알아야 할 점 설명 이미지

Liver Cancer Screening Frequency and Treatment Options

To prevent liver cancer, it is recommended to undergo two types of tests twice a year. Ultrasound and blood tests are primarily used for early detection of HCC.

Patients with cirrhosis or chronic hepatitis should have regular check-ups as they are at higher risk for developing HCC. Getting tested twice yearly can help reduce the likelihood of liver cancer development.

Expansion of Liver Transplant Facilities and New Treatment Opportunities

As liver transplant facilities in South Korea expand, new treatment opportunities become available for cancer patients. Success stories from institutions like Seoul National University Hospital and Bucheon St. Mary's Hospital illustrate this progress.

With increasing demand for liver transplants, facility expansion and training of specialized medical staff are also progressing, allowing HCC patients to choose more treatment options.

Lack of Specialized Information for Hepatocellular Carcinoma Patients

Specialized information specifically for hepatocellular carcinoma (HCC) patients is difficult to find in search results. Instead, general information on the success rates of liver transplantation, blood type compatibility, and early detection screenings is emphasized.

For HCC patients, managing underlying conditions related to cancer development is crucial, which can improve stability before and after liver transplant surgery. This should be considered alongside general information.

Key Information to Verify

When diagnosed with HCC, it is essential to confirm whether the patient has cirrhosis or chronic hepatitis as underlying conditions. This is critical for developing an effective treatment plan.

Early detection through two tests twice a year (ultrasound and blood tests) allows for determining the appropriate timing for liver transplantation. Additionally, considering that transplants are possible even with blood type differences can help in planning the surgery.

Frequently Asked Questions

Can living donor liver transplantation be applied to patients previously deemed ineligible?

Yes, living donor liver transplantation is applicable to patients who were previously considered ineligible, with a one-year survival rate of 95%.

Is it possible to have a liver transplant even if blood types differ?

Yes, liver transplants are now possible despite blood type differences, thanks to recent technological advancements that have overcome compatibility issues.

Can donors donate part of their liver through a small incision in the pelvic area?

Yes, donors can safely donate part of their liver with only a small incision in the pelvic area.

Frequently Asked Questions

For patients with hepatocellular carcinoma (HCC), living donor liver transplantation offers promising success rates and blood type compatibility. Regular biannual screenings (ultrasound and blood tests) enable early detection, while managing underlying conditions can maximize treatment effectiveness.

Seoul National University Hospital's achievement of 3,000 liver transplants and the transfer of technology to Mongolia demonstrate how technological advancements provide new hope for HCC patients. For HCC patients, confirming underlying causes and prioritizing regular check-ups are essential for early detection.

Read More Related Articles

You can view similar articles in one place.

View Related Articles

FAQ

Can living donor liver transplantation be applied to patients previously deemed ineligible?

Yes, living donor liver transplantation is applicable to patients who were previously considered ineligible, with a one-year survival rate of 95%.

Is it possible to have a liver transplant even if blood types differ?

Yes, liver transplants are now possible despite blood type differences, thanks to recent technological advancements that have overcome compatibility issues.

Can donors donate part of their liver through a small incision in the pelvic area?

Yes, donors can safely donate part of their liver with only a small incision in the pelvic area.

Korean Source

This article is an English localization of a Korean-language report from BlogScore. Original: 심철종 간암 환자, 간이식 수술 전 알아야 할 점